Ezatiostat Hydrochloride

DRUG3 trials

Sponsors

Telik

Conditions

Myelodysplastic SyndromeMyelodysplastic Syndrome (MDS)Severe Chronic Neutropenia

Phase 1

Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

CompletedNCT01062152

TelikMyelodysplastic Syndrome

Start: 2009-11-30End: 2013-03-31Updated: 2013-06-06

Phase 2

Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)

CompletedNCT00700206

TelikMyelodysplastic Syndrome (MDS)

Start: 2008-05-31End: 2011-07-31Target: 86Updated: 2011-10-12

Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia

TerminatedNCT00909584

TelikSevere Chronic Neutropenia

Start: 2009-04-30End: 2013-05-31Updated: 2013-11-25